South Korean chemical maker DL Chemical launched operations at its new polyisoprene latex plant in Singapore’s Jurong Island, cementing its position in the medical materials sector.
The 480 billion won ($366 million) facility, spanning 61,000 square meters, becomes the world’s largest producer of the synthetic rubber used in surgical gloves. The plant bolsters production capacity of DL Chemical’s Cariflex unit, which the company acquired in 2020 for 620 billion won ($473 million).
Cariflex maintains a unique market position as the sole manufacturer of anionic catalyst-based synthetic rubber and latex, materials valued in medical applications for their purity and clarity. The Singapore location offers strategic advantages through its established infrastructure and proximity to Asian markets.
DL Chemical executives indicated plans for additional expansion at the site, citing rising global demand for medical-grade materials. The investment marks a shift in the company’s portfolio toward specialized products with higher profit margins.
The facility’s opening comes as manufacturers worldwide seek to diversify their medical supply chains following disruptions during recent years. Industry analysts expect the medical latex market to see sustained growth, driven by healthcare sector demands.
